SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,415,000 | +15.1% | 7,728 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $1,229,000 | +78.1% | 7,728 | +7.3% | 0.00% | +50.0% |
| Q4 2018 | $690,000 | -34.3% | 7,200 | -3.2% | 0.00% | -33.3% |
| Q3 2018 | $1,050,000 | -14.6% | 7,437 | -5.3% | 0.00% | 0.0% |
| Q2 2018 | $1,229,000 | +6.9% | 7,850 | +10.0% | 0.00% | 0.0% |
| Q1 2018 | $1,150,000 | -19.2% | 7,137 | -76.9% | 0.00% | -40.0% |
| Q3 2016 | $1,424,000 | +32.0% | 30,916 | -13.7% | 0.01% | +25.0% |
| Q2 2016 | $1,079,000 | -6.0% | 35,816 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,148,000 | -37.9% | 35,816 | +12.9% | 0.00% | -42.9% |
| Q4 2015 | $1,849,000 | +40.0% | 31,716 | +1.6% | 0.01% | +40.0% |
| Q3 2015 | $1,321,000 | -45.0% | 31,216 | -5.2% | 0.01% | -37.5% |
| Q2 2015 | $2,403,000 | +174.0% | 32,916 | +88.6% | 0.01% | +166.7% |
| Q1 2015 | $877,000 | – | 17,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |